Figure 1.
Flowchart of patient enrollment. In total, 124 patients were randomized and treated with either VAM triple therapy or VAC triple therapy. Five patients dropped out or interrupted their therapy. VAC triple therapy: vonoprazan + amoxicillin + clarithromycin 1‐week eradication therapy; VAM triple therapy: vonoprazan + amoxicillin + metronidazole 1‐week eradication therapy.